-+ 0.00%
-+ 0.00%
-+ 0.00%

ACTINOGEN XANAMIA PIVOTAL ALZHEIMER’S DISEASE TRIAL COMPLETES FINAL PATIENT VISIT, WITH TOPLINE RESULTS ON TRACK FOR NOVEMBER

Reuters·09/23/2026 12:32:31